We sat down with Dawn Velligan, PhD, at the American College of Neuropsychopharmacology 2023 Annual Meeting right after the session, "Avolition as a Treatment Target Across Neuropsychiatric Conditions: Characteristics, Determinants, Potential Treatment Strategies, and Perspectives Based on Lived Experience." She shared a little bit about why she's excited about this year's conference.

Dr Velligan is a professor in the department of Psychiatry at the University of Texas Health Science Center.